18 results on '"KAWABE, KAZUKI"'
Search Results
2. Characterization of in vivo α1-adrenoceptor (R) binding of JIU-601 (JTH), a novel αL-R antagonist, in rats
3. Tissue selectivity of in vivo α1-adrenoceptor (R) binding in rats by KMD-3213 (KMD), a novel α1-R antagonist
4. Characterization of α1-adrenoceptor subtype in human urethra: A high coincidence with cloned human α1C-adrenoceptor
5. In vivo binding of [3H]YM617 to α1-adrenoceptor (AdR) in rats.
6. Binding characteristics of [3H]-YM617, a novel radioligand of α1-adrenoceptors (AdR) in human prostate.
7. α1-Adrenoceptors in human prostate and aorta: Comparison of the receptor binding affinity of α1 antagonists
8. α2-adrenoceptor binding in prostates from patients with benign prostatic hypertrophy (BPH).
9. Alpha-1 adrenoceptor binding in prostates from patients with benign prostatic hypertrophy(BPH)
10. O-59 - In vivo α1-adrenoceptor (R) binding characteristics and pharmacological effects of JTH-601 (novel αIL-R antagonist) and its metabolites
11. P-300 - Characterization of in vivo α1-adrenoceptor (R) binding of JIU-601 (JTH), a novel αL-R antagonist, in rats
12. O-62 - Tissue selectivity of in vivo α1-adrenoceptor (R) binding in rats by KMD-3213 (KMD), a novel α1-R antagonist
13. P2-185 - Characterization of α1-adrenoceptor subtype in human urethra: A high coincidence with cloned human α1C-adrenoceptor
14. O-358 - α1-Adrenoceptors in human prostate and aorta: Comparison of the receptor binding affinity of α1 antagonists
15. P-130 - α2-adrenoceptor binding in prostates from patients with benign prostatic hypertrophy (BPH).
16. O-416 - In vivo binding of [3H]YM617 to α1-adrenoceptor (AdR) in rats.
17. P-614 - Binding characteristics of [3H]-YM617, a novel radioligand of α1-adrenoceptors (AdR) in human prostate.
18. O-180 - Alpha-1 adrenoceptor binding in prostates from patients with benign prostatic hypertrophy(BPH)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.